ROTHBLATT MARTINE A
SEC CIK 1106578 · EDGAR
BoughtSold
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $841.11M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 665
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-05 | 2024-03-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $232.83 | -15.9K | 2,372 | -87% | -$3.71M |
| DM | 2023-05-03 | 2023-05-02 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $228.59 | -8,000 | 3,714 | -68% | -$1.83M |
| D | 2023-05-03 | 2023-05-02 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +8,000 | 8,130 | +6,154% | +$904.6K |
| DM | 2023-05-02 | 2023-04-28+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-05-02 | 2023-04-28+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $230.36 | -16.0K | 130 | -99% | -$3.69M |
| DM | 2023-04-28 | 2023-04-26+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $226.26 | -16.0K | 638 | -96% | -$3.62M |
| DM | 2023-04-28 | 2023-04-26+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-04-26 | 2023-04-24+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $227.34 | -16.0K | 3,585 | -82% | -$3.64M |
| DM | 2023-04-26 | 2023-04-24+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-04-24 | 2023-04-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-04-24 | 2023-04-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $226.86 | -16.0K | 2,142 | -88% | -$3.63M |
| DM | 2023-04-20 | 2023-04-18+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $226.45 | -16.0K | 191 | -99% | -$3.62M |
| DM | 2023-04-20 | 2023-04-18+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-04-18 | 2023-04-14+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $229.48 | -16.0K | 5,090 | -76% | -$3.67M |
| DM | 2023-04-18 | 2023-04-14+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-04-14 | 2023-04-12+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $228.92 | -16.0K | 130 | -99% | -$3.66M |
| DM | 2023-04-14 | 2023-04-12+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-04-12 | 2023-04-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $224.89 | -16.0K | 130 | -99% | -$3.60M |
| DM | 2023-04-12 | 2023-04-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-04-07 | 2023-04-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-04-07 | 2023-04-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $230.23 | -16.0K | 216 | -99% | -$3.68M |
| DM | 2023-04-05 | 2023-04-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-04-05 | 2023-04-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $225.65 | -16.0K | 2,781 | -85% | -$3.61M |
| DM | 2023-04-03 | 2023-03-31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $221.52 | -8,000 | 5,184 | -61% | -$1.77M |
| D | 2023-04-03 | 2023-03-31 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +8,000 | 8,130 | +6,154% | +$904.6K |
| DM | 2023-03-31 | 2023-03-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $217.34 | -16.0K | 4,212 | -79% | -$3.48M |
| DM | 2023-03-31 | 2023-03-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-03-30 | 2023-03-28 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $219.98 | -8,000 | 130 | -98% | -$1.76M |
| D | 2023-03-30 | 2023-03-28 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +8,000 | 8,130 | +6,154% | +$904.6K |
| DM | 2023-03-28 | 2023-03-24+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $217.50 | -16.0K | 130 | -99% | -$3.48M |
| DM | 2023-03-28 | 2023-03-24+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-03-24 | 2023-03-22+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $215.23 | -16.0K | 1,791 | -90% | -$3.44M |
| DM | 2023-03-24 | 2023-03-22+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-03-22 | 2023-03-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $223.90 | -16.0K | 4,053 | -80% | -$3.58M |
| DM | 2023-03-22 | 2023-03-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-03-20 | 2023-03-16+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $217.74 | -16.0K | 528 | -97% | -$3.48M |
| DM | 2023-03-20 | 2023-03-16+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-03-16 | 2023-03-14+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $219.86 | -16.0K | 1,565 | -91% | -$3.52M |
| DM | 2023-03-16 | 2023-03-14+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-03-14 | 2023-03-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-03-14 | 2023-03-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $227.84 | -16.0K | 4,463 | -78% | -$3.65M |
| DM | 2023-03-10 | 2023-03-08+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $224.72 | -16.0K | 7,494 | -68% | -$3.60M |
| DM | 2023-03-10 | 2023-03-08+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-03-08 | 2023-03-06+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $243.22 | -16.0K | 311 | -98% | -$3.89M |
| DM | 2023-03-08 | 2023-03-06+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-03-06 | 2023-03-02+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $245.94 | -16.0K | 4,458 | -78% | -$3.94M |
| DM | 2023-03-06 | 2023-03-02+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-03-02 | 2023-02-28+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $245.24 | -16.0K | 7,652 | -68% | -$3.92M |
| DM | 2023-03-02 | 2023-02-28+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-02-28 | 2023-02-24+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-02-28 | 2023-02-24+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $249.21 | -16.0K | 6,003 | -73% | -$3.99M |
| DM | 2023-02-24 | 2023-02-22+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $247.64 | -16.0K | 3,139 | -84% | -$3.96M |
| DM | 2023-02-24 | 2023-02-22+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-02-22 | 2023-02-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $254.74 | -16.0K | 1,105 | -94% | -$4.08M |
| DM | 2023-02-22 | 2023-02-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-02-17 | 2023-02-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $251.78 | -16.0K | 399 | -98% | -$4.03M |
| DM | 2023-02-17 | 2023-02-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-02-15 | 2023-02-13+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $254.66 | -16.0K | 6,148 | -72% | -$4.07M |
| DM | 2023-02-15 | 2023-02-13+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-02-13 | 2023-02-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-02-13 | 2023-02-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $254.06 | -16.0K | 130 | -99% | -$4.06M |
| DM | 2023-02-09 | 2023-02-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $253.35 | -16.0K | 6,710 | -70% | -$4.05M |
| DM | 2023-02-09 | 2023-02-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-02-07 | 2023-02-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $256.04 | -16.0K | 6,603 | -71% | -$4.10M |
| DM | 2023-02-07 | 2023-02-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-02-03 | 2023-02-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $258.28 | -16.0K | 4,636 | -78% | -$4.13M |
| DM | 2023-02-03 | 2023-02-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-02-01 | 2023-01-30+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $260.76 | -16.0K | 2,049 | -89% | -$4.17M |
| DM | 2023-02-01 | 2023-01-30+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-01-30 | 2023-01-26+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | 0 | 8,130 | New | $0 |
| DM | 2023-01-30 | 2023-01-26+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $262.11 | -16.0K | 130 | -99% | -$4.19M |
| DM | 2023-01-26 | 2023-01-24+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $261.88 | -16.0K | 5,280 | -75% | -$4.19M |
| DM | 2023-01-26 | 2023-01-24+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | 0 | 8,130 | New | $0 |
| DM | 2023-01-24 | 2023-01-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-01-24 | 2023-01-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $259.79 | -16.0K | 5,101 | -76% | -$4.16M |
| DM | 2023-01-20 | 2023-01-18+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $259.83 | -16.0K | 2,507 | -86% | -$4.16M |
| DM | 2023-01-20 | 2023-01-18+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-01-18 | 2023-01-13+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $261.01 | -16.0K | 130 | -99% | -$4.18M |
| DM | 2023-01-18 | 2023-01-13+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-01-13 | 2023-01-11+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $261.83 | -16.0K | 6,281 | -72% | -$4.19M |
| DM | 2023-01-13 | 2023-01-11+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-01-11 | 2023-01-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $265.69 | -16.0K | 339 | -98% | -$4.25M |
| DM | 2023-01-11 | 2023-01-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-01-09 | 2023-01-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $274.82 | -16.0K | 7,650 | -68% | -$4.40M |
| DM | 2023-01-09 | 2023-01-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-01-05 | 2023-01-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $272.77 | -16.0K | 130 | -99% | -$4.36M |
| DM | 2023-01-05 | 2023-01-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2023-01-03 | 2022-12-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $276.05 | -16.0K | 2,775 | -85% | -$4.42M |
| DM | 2023-01-03 | 2022-12-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-12-29 | 2022-12-27+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $274.02 | -16.0K | 700 | -96% | -$4.38M |
| DM | 2022-12-29 | 2022-12-27+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-12-27 | 2022-12-22+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $276.27 | -16.0K | 4,834 | -77% | -$4.42M |
| DM | 2022-12-27 | 2022-12-22+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-12-22 | 2022-12-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $273.59 | -16.0K | 6,860 | -70% | -$4.38M |
| DI | 2022-12-22 | 2022-12-20 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | G - Gift | — | -7,366 | 644.2K | -1% | — |
| DM | 2022-12-22 | 2022-12-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| DM | 2022-12-20 | 2022-12-16+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $274.21 | -16.0K | 1,677 | -91% | -$4.39M |
| DM | 2022-12-20 | 2022-12-16+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +16.0K | 8,130 | New | +$1.81M |
| D | 2022-12-19 | 2022-12-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $113.08 | +8,000 | 8,130 | +6,154% | +$904.6K |
| DM | 2022-12-19 | 2022-12-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $275.36 | -8,000 | 1,964 | -80% | -$2.20M |
Purchase Sale Sale after option exercise All abbreviations